Разрешен к применению с 1995 года.
Видео о
Купить в
COVID-19 
По алфавиту
V.K. Kozlov, N.A. Bubnova, G.M. Kurmanova 
PDF
Possibilities of cytokine therapy in purulent-septic surgical pathology.
Medici.com. 2025. №127. P. 80-82.
van den Heuvel MM, Verheij M, Boshuizen R et al.
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy.J Transl Med. 2015 Jan 27;13:32. doi: 10.1186/s12967-015-0397-0. PMID: 25622640; PMCID: PMC4320467.
Velasco I, Campos A, Acien P
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage, and intracystic recombinant interleukin-2.2005-04, Fertil Steril., 83(4):873-7.
Velotti F, Stoppacciaro A, Ruco L et al.
Local activation of immune response in bladder cancer patients treated with intraarterial infusion of recombinant interleukin-2.Cancer Res. 1991 May 1;51(9):2456-62. PMID: 2015606.
Velotti F, Tubaro A, Stoppacciaro A et al.
Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.Ann Ist Super Sanita. 1990;26(3-4):411-21. PMID: 2091503.
Veronika Niederlova, Oksana Tsyklauri ,Marek Kovar, Ondrej Stepanek. PDF
Trends in immunology. – 2023. – V. 44, Is. 11, P. 890-901. DOI: 10.1016/j.it.2023.09.003
Vlasveld L.T., Beijnen J.H., Sein J.J. et al.
Reconstitution of Recombinant interleukin-2 (rIL-2): A Comparative Study of Various rIL-2 Muteins.European J of Cancer. 1993. 29A (14): p.1977-1979.
Volodin N.N., Soldatova I.G., Degtyareva M.V.
Evidence-based immunotherapeutical approaches in treatment of severe neonatal bacterial infections.
ISEH 37th Annual Scientific Meeting. Boston, MA, USA. Abstract Supplement. Experimental Hematology. 2008. Vol. 36. Suppl. 1 (S1-S99). S91.
Vose BM, Bonnard GD.
Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.J Immunol. 1983 Feb;130(2):687-93. PMID: 6600251.
Vujanovic NL, Yasumura S, Hirabayashi H et al.
Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.J Immunol. 1995 Jan 1;154(1):281-9. PMID: 7995947.
В соответствии с п. 1 ст. 64 Федерального закона от 12.04.2010 № 61-ФЗ "Об обращении лекарственных средств" лекарственные препараты, находящиеся в обращении на территории Российской Федерации, подлежат мониторингу безопасности в целях выявления возможных негативных последствий их применения, предупреждения пациентов и их защиты от применения таких препаратов.